Relay Therapeutics Inc (RLAY)

NASDAQ
34.24
-0.01(-0.03%)
  • Volume:
    187,242
  • Bid/Ask:
    31.18/35.43
  • Day's Range:
    33.40 - 34.79

RLAY Overview

Prev. Close
34.25
Day's Range
33.4-34.79
Revenue
83.6M
Open
34.27
52 wk Range
26.44-64.37
EPS
-2.87
Volume
187,242
Market Cap
3.16B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
-
1-Year Change
3.13%
Shares Outstanding
92,382,360
Next Earnings Date
Nov 18, 2021
What is your sentiment on Relay Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Relay Therapeutics Inc News

Relay Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralNeutralSell
Technical IndicatorsStrong SellStrong SellBuyBuyNeutral
SummaryStrong SellStrong SellNeutralNeutralNeutral

Relay Therapeutics Inc Company Profile

Relay Therapeutics Inc Company Profile

Employees
163

Relay Therapeutics Inc. is a clinical-stage precision medicines company. The Company is focused on transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The Company is advancing a pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-1971 and RLY-4008, as well as its PI3Ka mutant selective program (RLY-PI3K1047 program). Its RLY-1971 binds and stabilizes Src homology region two (SH2)-containing protein tyrosine phosphatase two (SHP2) in its inactive conformation. Its RLY-4008, is it inhibitor of fibroblast growth factor receptor 2 (FGFR2), enriched for patients with advanced solid tumors having oncogenic FGFR2.

Read More
  • someone have more info for this company ?
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.